Avanir Targets Wockhardt In Nuedexta Patent Blitz

Law360, New York (August 30, 2011, 4:10 PM EDT) -- Avanir Pharmaceuticals Inc. on Tuesday sued drugmaker Wockhardt Ltd. in an effort to block its plans to make a generic version of mental health drug Nuedexta, marking the latest complaint in a campaign of patent suits over the drug.

Avanir claims that Mumbai, India-based Wockhardt's planned version of the drug, which treats involuntary laughing and crying disorders in patients with underlying brain conditions, infringes two of its patents.

The lawsuit broadens Avanir's fight to retain control of the drug's manufacture. Earlier in August, it sued two...
To view the full article, register now.